Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

155 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-02-26

Study Completion Date

2025-02-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pre-eclampsia is a disease characterized by placental damage leading to a cascade of complications during pregnancy. It is initially manifested by high blood pressure and the presence of albumin in the urine. It can lead to emergency hospitalization in severe cases and cause major complications or even death in the mother and the fetus.

Several studies observing the outcome of patients with pre-eclampsia have shown an increased long-term cardiovascular risk in these patients, justifying regular medical follow-up with the treating physician and specialists, mainly cardiologists.

The main objective of this research is to describe the cardiovascular risk assessment actions implemented by the treating general practitioner in the year following pre-eclampsia (blood pressure measurement in the office, self-measurement of blood pressure, ABPM, cardiological consultation, biological monitoring of blood (creatininemia, LDL, fasting glycemia) or urine (albuminurie/creatininurie ratio), and screening and management of possible smoking).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Chronic Remote Ischemic Preconditioning as a Complement to Conventional Prenatal Care for Preeclampsia

NCT05564988

Preeclampsia

NOT_YET_RECRUITING NA

Cardiovascular Changes in Infants of Preeclampsia Mother

NCT04699825

Pre-Eclampsia

UNKNOWN NA

Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care

NCT05056701

Preeclampsia

RECRUITING NA

First-trimester Prediction of Preeclampsia

NCT02189148

Preeclampsia Severe Preeclampsia Fetal Growth Restriction +1 more

COMPLETED

Study of the Physiology of Pre-eclampsia and Vascular IUGR With Constitution of a Biological Collection

NCT03626233

Pre-Eclampsia

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patients Hospitalized for Pre-eclampsia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient with pre-eclampsia

Cardiovascular risk assessment by the general practitioner in the year following pre-eclampsia

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients ≥ 18 years hospitalized for preeclampsia at the Nancy regional maternity hospital

Exclusion Criteria

* Fetal death in utero;
* Adult Person subject to a legal protection measure (guardianship, curatorship, safeguard of justice);
* Person deprived of liberty by a judicial or administrative decision;
* Person subject to psychiatric care under constraint by virtue of articles L. 3212-1 and L. 3213-1 of the Public Health Code.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No